• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aiforia's H1 revenue was surprisingly subdued

AIFORIAAnalyst Comment22.07.2026, 08.05
Antti SiltanenAnalyst
Discuss

Summary

  • Aiforia's revenue for January-June was approximately 0.75 MEUR, a 46% decrease from the previous year, falling short of both company and analyst expectations.
  • The company attributes the weak performance to delays in customer contracts and expects revenue from new contracts to be recognized in the second half of the year.
  • Aiforia's order book at the end of H1 was 3.5 MEUR, down from 5.1 MEUR a year ago, indicating slower growth in recurring revenue.
  • Despite the revenue shortfall, Aiforia's recent 6.4 MEUR funding is deemed sufficient until H1'27, with additional potential financing from the European Investment Bank.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 07/22/2026 at 08:23 am EEST

Aiforia announced on Tuesday that its revenue for the beginning of the year has turned out clearly below the company's own and our expectations. The company estimates that January–June revenue will decrease significantly from the comparison period to around 0.75 MEUR (H1'25: 1.4 MEUR). According to the company, revenue from new customers announced in H1 should materialize in H2. In recent years, the company has announced several customer wins, but their conversion into significant recurring revenue seems to be taking a long time. The profit warning naturally has a negative impact on our estimates and investment view, which we will update in the near future.

Slow revenue recognition from customer contracts is slowing growth

Aiforia's January-June revenue of around 0.75 MEUR represents a decrease of approximately 46% compared to the comparison period. The outcome falls sharply short of our expectations, as we had estimated revenue of 2.3 MEUR for the beginning of the year, following a successful H2'25. According to the company, the weak performance was due to delays in ongoing customer contracts and the fact that revenue from new contracts signed during the early part of the year (such as the Paris and Spain hospital expansions) will only start to be recognized in the second half of the year. The company has consistently reported new customer accounts over the past couple of years, but the recurring revenue generated from them is still very modest and appears to be growing slowly. In Aiforia's business model, the value of contracts is recognized as revenue based on usage, which makes the growth rate highly sensitive to the schedules of customers' own processes. The order book of 3.5 MEUR at the end of H1 provides support for future revenue development. However, the order book is modest compared to a year ago (H1'25: 5.1 MEUR).

Funding is sufficient for next year even without the EIB loan

The company stated that the weak performance in the beginning of the year does not cause revisions to its previously issued mid-term targets. However, the sluggishness in H1 means clear downward pressure on our 2026 estimates, as our expected growth curve is once again pushed forward. Regarding funding, Aiforia recently raised 6.4 MEUR through a directed issue. We believe this funding is sufficient until H1'27. In addition, the company has a letter of intent for 20 MEUR in venture debt financing with the European Investment Bank. The slow progress of the company also increases uncertainty from a financing perspective.

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures08.03

202526e27e
Revenue3.55.17.9
growth-%24.0 %45.0 %55.0 %
EBIT (adj.)-11.2-9.2-8.3
EBIT-% (adj.)-316.3 %-178.7 %-104.7 %
EPS (adj.)-0.38-0.25-0.19
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

An EIB director from the division in question is also highlighting this Aiforia funding on LinkedIn. LinkedIn #ai #life #investeu | Y Zhang ...
8/10/2026, 6:15 AM
by Puutaheinää
8
European Investment Bank TECHEU VD AI FOR IMAGING ANALYSIS (BIOTECH ACT) The project focuses on developing and deploying an advanced, cloud-...
8/10/2026, 5:29 AM
by Salvelinus
10
Have you used this: Kukaomistaa.fi — Helsinki Stock Exchange ownership register. It is easy and clear to use, and the information seems to be...
8/5/2026, 7:31 AM
10
Here are the ten largest shareholders and the change in July 1 Citibank Europe Plc 6,794,620 +1,733 31.7.2026 2 Skandinaviska Enskilda Banken...
8/5/2026, 7:09 AM
by Uuno
1
A small obstacle has appeared in my favorite pastime: the list of Aiforia’s largest shareholders won’t open for me. Is anyone else having the...
8/5/2026, 6:19 AM
1
I have kept a relatively small tracking position, which I have then steadily topped up on dips—perhaps foolishly, but blindly believing in domestic...
8/3/2026, 9:42 AM
by Pekka
7
Any financing solution that is good for the shareholders requires favorable sales development for Aiforia. If that doesn’t happen, the share...
8/3/2026, 7:39 AM
by Puutaheinää
9